Potassium titanyl phosphate laser prostatectomy: A review

Current Opinion in Urology

Volumn 17, Issue 1, 2007, Pages 22-26

  Chandrasekera, Srinath ^a   Muir, Gordon ^b  

^a Faculty of Medical Sciences   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; GreenLight; Photovaporization of prostate; Potassium titanyl phosphate laser; Prostatectomy

Indexed keywords

BLOOD TRANSFUSION; CLINICAL TRIAL; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INTRAOPERATIVE PERIOD; LASER SURGERY; NEODYMIUM LASER; POTASSIUM TITANYL PHOSPHATE LASER PROSTATECTOMY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; SAFETY; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TRANSURETHRAL RESECTION; URINE FLOW RATE;

HUMANS; LASER SURGERY; MALE; PHOSPHATES; PROSTATE; PROSTATIC HYPERPLASIA; TITANIUM; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 33845418923     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32801145fc     Document Type: Review

References (37)

1. Costello AJ, Bowsher WG, Bolton DM, et al. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 1992; 69:603-608.
2. McAllister WJ, Absalom MJ, Mir K, et al. Does endoscopic laser ablation of the prostate stand the test of time? Five-year results from a multicentre randomized controlled trial of endoscopic laser ablation against transurethral resection of the prostate. BJU Int 2000; 85:437-439.
3. Anson KM, Watson GM, Shah TK, Barnes DG. Laser prostatectomy: our initial experience of a technique in evolution. J Endourol 1993; 7:333-336.
4. Martenson AC, De La Rosette JJ. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode laser system: results of an evolving technology. Prostate Cancer Prostatic Dis 1999; 2:148-154.
5. Chandrasekera SK, Muir GH. Surgical therapy for symptomatic benign prostatic hyperplasia. 12th ed. Shrewsbury, UK: TFM Publishing Ltd.; 2005. A comprehensive review comparing TURP, open prostatectomy, holmium laser and KTP laser prostatectomy.
6. Naspro R, Salonia A, Cestari A, et al. A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia. BJU Int 2005; 96:736-739. An easy-to-understand well presented paper on the basics of lasers for prostate ablation.
7. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997; 49:703-708.
8. Barber NJ, Muir GH. High-power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate. Curr Opin Urol 2004; 14:21-25.
9. Hurle R, Vavassori I, Piccinelli A, et al. Holmium laser enucleation of the prostate combined with mechanical morcellation in 155 patients with benign prostatic hyperplasia. Urology 2002; 60:449-453.
10. Malek RS, Nahen K. Laser treatment of obstructive BPH - problems and progress. Contemp Urol 2004; 37-43.
11. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanylphosphate laser vaporization prostatectomy. J Urol 2000; 163:1730-1733.
12. Malek RS, Nahen K. Photoselective vaporization of the prostate: KTP laser therapy of obstructive benign prostatic hyperplasia. AUA Update Ser 2004; 23:153-160.
13. Anson K. Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol 2004; 14:27-29.
14. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium- titanylphosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005; 174 (Pt 1):1344-1348. An excellent summary of the key studies on the high-power KTP system.
15. Malek RS. Photoselective KTP laser vaporization of obstructive BPH (PVP). In: Baba S, Ono Y, editors. Interventional management of urological diseases. Tokyo: Springer-Verlag; 2006. pp. 103-122. A comprehensive review of KTP laser prostatectomy. This chapter summarizes most of the work done on KTP laser since its inception.
16. Carter A, Sells H, Speakman M, et al. A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 1999; 83:254-259.
17. Alexis E, Terrence R, Malloy BS, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States Multicenter Prospective Trial. J Urol 2004; 172 (Pt 1):1404-1408.
18. Bouchier-Hayes DM, Anderson P, Appledom SV, et al. A randomised trial comparing photo-vaporisation and trans-urethral resection of the prostate in patients with BPH [abstract]. J Urol 2005; 173 (Suppl 1555):421. The only randomized study so far [abstract only]
19. Chandrasekera SK, Barber NJ, Walsh K, Thompson PM, et al. High power 80W Nd:YAG/KTP laser vaporization of the prostate with 1 year follow up [abstract]. Lasers Surg Med 2005; (Suppl 17):69.
20. Larner T, Nawrocki J. Photoselective vaporization of the prostate for BPH outcome at 3 months in our first 50 unselected patients. BJU Int 2004; 93:110.
21. Volkan T, Ihsan TA, Yilmaz O, et al. Short term outcomes of high power (80W) potassium titanyl-phosphate laser vaporization of the prostate. Eur Urol 2005; 48:608-613.
22. Fu WJ, Hong BF, Yang Y, et al. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia. Chin Med J 2005; 118:1610-1614.
23. Bachmann A, Schurch L, Ruzart R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005; 48:965-971. One of the few comparative studies available up to date.
24. De la Rosette J, Madersbacher S, Alivizatos G, et al. Guidelines on benign prostatic hyperplasia. Eur Urol 2001; 40:256-263.
25. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium- titanylphosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 1996; 48:575-583.
26. Mueller N, Mueller EJ. KTP photoselective laser vaporization of the prostate: indications, procedure, and nursing implications. Urol Nurs 2004; 24:373-378.
27. Ruszat R, Wyler S, Seifert HH, et al. Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol 50; 2006:1040-1049. [Epub 2006 Jan 3]. A useful account to appreciate differences in outcome in those with urinary retention and it is one of the few papers addressing the issue of PVP for those in urinary retention.
28. Sarica K, Alkan E, Luleci H, Tasci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 2005; 19:1199-1202.
29. Mearini E, Marzi M, Mearini L, et al. Open prostatectomy in benign prostatic hyperplasia: 10-year experience in Italy. Eur Urol 1998; 34:480-485.
30. Serretta V, Morgia G, Fondacaro L, et al. Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology 2002; 60:623-627.
31. Barber NJ, Zhu G, Donohue JF, et al. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate. Urology 2006; 67:80-83. A landmark paper confirming the absence of transurethral resection syndrome with PVP. This study further justifies the utility of PVP in large adenomata and high-risk patients.
32. Sandhu JS, Ng C, Vanderbrink BA, et al. High-power potassium- titanylphosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004; 64:1155-1159.
33. 3. J Urol 2005; 173 (Suppl 1569): 425.
34. Reich O, Bachmann A, Siebels M, et al. High power (80W) potassium-titanylphosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005; 173:158-160.
35. Sandhu JS, Ng CK, Gonzalez RR, et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005; 19:1196-1198.
36. Fu WJ, Hong BF, Wang XX, et al. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl 2006; 8:367-371.
37. Kumar SM. Photoselective vaporization of the prostate (PVP): a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 2005; 173:511-513.